Interpace Biosciences Inc (IDXG) stock news · P/E 1.8, rev $18.2M
Interpace Biosciences Inc (IDXG) is a diagnostics & research company listed on OTCQX.
This IDXG news page leads with what Interpace Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for IDXG yet. We will not pad this page with generic market recap.
Latest reported IDXG revenue for 2026-06-30 was $18.2M. Net income was $879.0K. IDXG currently screens at market cap $43.5M and trailing P/E 1.8.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IDXG stock page; for the tape open the quote page.
Not investment advice.